Cost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada-Reference-Cited by-同舟云学术

Cost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada

Published:2020-02-07 Issue:6 Volume:23 Page:631-640
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Johnston Karissa¹,Danchenko Natalya²,Hansen Ryan³,Dinet Jerome⁴,Liovas Anna⁴,Armstrong Ava⁴,Bains Savreet⁵,Sullivan Sean D.³

Affiliation:

1. Broadstreet Health Economics and Outcomes Research, Vancouver, Canada;

2. Ipsen Global, Boulogne-Billancourt, France;

3. Choice Institute, University of Washington, Seattle, WA, USA;

4. Ipsen Biopharmaceuticals Canada, Mississauga, Canada;

5. Ipsen US, Basking Ridge, NJ, USA

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1722138

Reference48 articles.

1. Epidemiology of cerebral palsy

2. Abdel-Hamid HZ, Bazzano ATF, Ratanawongsa B. Cerebral Palsy. Medscape. 2018. [cited 2020 Jan 31]. Available from https://emedicine.medscape.com/article/1179555-overview

3. Spasticity in children

4. Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity

5. The Child with Cerebral Palsy: Diagnosis and Beyond

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing Criteria for Health Economic Quality Evaluation Tool;Value in Health;2023-08

2. Comparative efficacy, safety, and cost-effectiveness of abobotulinumtoxinA and onabotulinumtoxinA in children with upper limb spasticity: a systematic literature review, indirect treatment comparison, and economic evaluation;Journal of Medical Economics;2021-01-01